Atıf Formatları
Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Karabulut Et Al. , "Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus.," Fetal and pediatric pathology , vol.40, pp.103-112, 2021

Karabulut, B. Et Al. 2021. Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus.. Fetal and pediatric pathology , vol.40 , 103-112.

Karabulut, B., ARCAGOK, B. C., & Simsek, A., (2021). Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus.. Fetal and pediatric pathology , vol.40, 103-112.

Karabulut, Birol, Baran Cengiz ARCAGOK, And Ayse Simsek. "Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus.," Fetal and pediatric pathology , vol.40, 103-112, 2021

Karabulut, Birol Et Al. "Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus.." Fetal and pediatric pathology , vol.40, pp.103-112, 2021

Karabulut, B. ARCAGOK, B. C. And Simsek, A. (2021) . "Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus.." Fetal and pediatric pathology , vol.40, pp.103-112.

@article{article, author={Birol Karabulut Et Al. }, title={Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus.}, journal={Fetal and pediatric pathology}, year=2021, pages={103-112} }